Licensing

Astion will seek to license its medicinal product development candidates after they have commenced clinical development. We conduct a clinical phase IIa proof of concept study and verify the basic efficacy, safety and tolerability profile prior to licensing.

Astion will seek to license the Medical Device Product line to be commercialized worldwide.


For licensing discussions please contact:

Astion Pharma A/S
Fruebjergvej 3
DK-2100 Copenhagen
DENMARK
Phone: +45 39 17 99 29


Søs Holten
Project Manager, MD
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +45 39 17 99 29


Peder Møller Andersen
VP medical Affairs, MD
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +45 20 80 24 70

Licensing strategy

Astion's overall licensing strategy is to find partners who can develop and commercialize the products worldwide.